These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8232)

  • 1. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.
    Greenblatt DJ; Joyce TH; Comer WH; Knowles JA; Shader RI; Kyriakopoulos AA; MacLaughlin DS; Ruelius HW
    Clin Pharmacol Ther; 1977 Feb; 21(2):222-30. PubMed ID: 13960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ; Comer WH; Elliott HW; Shader RI; Knowles JA; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):490-4. PubMed ID: 19508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA; Greenblatt DJ; Shader RI
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.
    Hümpel M; Illi V; Milius W; Wendt H; Kurowski M
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam kinetics in the elderly.
    Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of lorazepam.
    Elliott HW
    Br J Anaesth; 1976 Oct; 48(10):1017-23. PubMed ID: 10938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam: glucuronide formation in the cat.
    Schillings RT; Sisenwine SF; Schwartz MH; Ruelius HW
    Drug Metab Dispos; 1975; 3(2):85-8. PubMed ID: 236163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal impairment and hemodialysis on lorazepam kinetics.
    Morrison G; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1984 May; 35(5):646-52. PubMed ID: 6713774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and biotransformation of lormetazepam. II. Radioimmunologic determinations in plasma and urine of young and elderly subjects: first-pass effect.
    Hümpel M; Nieuweboer B; Milius W; Hanke H; Wendt H
    Clin Pharmacol Ther; 1980 Nov; 28(5):673-9. PubMed ID: 6108174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam.
    Greenblatt DJ; Franke K; Shader RI
    J Chromatogr; 1978 Sep; 146(2):311-20. PubMed ID: 29907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam.
    Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
    J Pharm Sci; 1982 Feb; 71(2):248-52. PubMed ID: 6121043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses.
    Caillé G; Spénard J; Lacasse Y; Brennan J
    Biopharm Drug Dispos; 1983; 4(1):31-42. PubMed ID: 6132630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolic fate of 14C-quazepam in man.
    Zampaglione N; Hilbert JM; Ning J; Chung M; Gural R; Symchowicz S
    Drug Metab Dispos; 1985; 13(1):25-9. PubMed ID: 2858372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of lorazepam. IV. Long-term oral administration.
    Greenblatt DJ; Knowles JA; Comer WH; Shader RI; Harmatz JS; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):495-500. PubMed ID: 19509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition pharmacokinetics of lorazepam in the rabbit.
    Nielsen-Kudsk F; Jakobsen P
    Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):388-91. PubMed ID: 6103631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cimetidine with oxazepam, lorazepam, and flurazepam.
    Greenblatt DJ; Abernethy DR; Koepke HH; Shader RI
    J Clin Pharmacol; 1984 Apr; 24(4):187-93. PubMed ID: 6144699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.